Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
EGRX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Eagle Pharmaceuticals, Inc.
EGRX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Eagle Pharmaceuticals, Inc.
EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Eagle Pharmaceuticals, Inc. on Behalf of Eagle Pharmaceuticals Stockholders and Encourages Investors to Contact the Firm
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Eagle Pharmaceuticals, Inc. (EGRX) on Behalf of Investors
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Eagle Pharmaceuticals, Inc. (EGRX)
Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call Transcript
Eagle Pharmaceuticals (EGRX) Q1 2022 Earnings Call Transcript
Eagle Pharmaceuticals (EGRX) Q4 2021 Earnings Call Transcript
Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript
Eagle Pharmaceuticals Inc (EGRX) Q1 2021 Earnings Call Transcript
Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript
About · FAQs · StocksCafe © 2024 · Privacy · Terms